# Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

Source: https://onco.cc/trials/nct06963840/  
OnCo record `nct06963840` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of an investigational treatment in ovarian cancer, run by Wellizen Australia, active and no longer recruiting.

## Summary

Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome is a phase 2 interventional study registered as NCT06963840 by Wellizen Australia, with 16 participants enrolled, started 2025-05-09 and due to reach its primary completion in 2025-08.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06963840
- Phase: 2
- Setting: Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
- Sponsor: Wellizen Australia
- Enrolled: 16

## Sources

- ClinicalTrials.gov NCT06963840: https://clinicaltrials.gov/study/NCT06963840

## Connected records

- cancers: [Ovarian cancer](https://onco.cc/cancers/ovarian/)

---
JSON: https://onco.cc/api/v1/entities/nct06963840.json